13F HOLDINGS REPORT
Paradigm Biocapital Advisors LP
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001855655-23-000008
Total Value
$1.29B
Positions
30
Other Managers
0
Confidential Omitted
No
Holdings (30)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LEGEND BIOTECH CORP | LEGN | 1,805,717 | $124.6M | 9.63% |
| 2 | INCYTE CORP | INCY | 1,381,711 | $86.0M | 6.65% |
| 3 | IMMUNOCORE HLDGS PLC | IMCR | 1,270,124 | $76.2M | 5.88% |
| 4 | ARCELLX INC | ACLX | 2,347,000 | $74.2M | 5.73% |
| 5 | KARUNA THERAPEUTICS INC | 48576A100 | 283,605 | $61.5M | 4.75% |
| 6 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 1,868,946 | $59.4M | 4.59% |
| 7 | ARGENX SE | ARGX | 150,000 | $58.5M | 4.52% |
| 8 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,415,256 | $57.5M | 4.44% |
| 9 | ARGENX SE | ARGX | 142,259 | $55.4M | 4.28% |
| 10 | UNITED THERAPEUTICS CORP DEL | UTHR | 238,388 | $52.6M | 4.07% |
| 11 | MIRATI THERAPEUTICS INC | 60468T105 | 1,443,762 | $52.2M | 4.03% |
| 12 | SYNDAX PHARMACEUTICALS INC | SNDX | 2,424,132 | $50.7M | 3.92% |
| 13 | BICYCLE THERAPEUTICS PLC | BCYC | 1,985,430 | $50.7M | 3.92% |
| 14 | NUVALENT INC | NUVL | 1,120,465 | $47.3M | 3.65% |
| 15 | BEIGENE LTD | BEIGF | 216,093 | $38.5M | 2.98% |
| 16 | XENON PHARMACEUTICALS INC | XENE | 989,327 | $38.1M | 2.94% |
| 17 | OLEMA PHARMACEUTICALS INC | OLMA | 3,731,046 | $33.7M | 2.60% |
| 18 | AMBRX BIOPHARMA INC | 02290A102 | 1,650,499 | $27.2M | 2.10% |
| 19 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,395,002 | $25.1M | 1.94% |
| 20 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 2,423,961 | $24.9M | 1.93% |
| 21 | VIR BIOTECHNOLOGY INC | VIR | 1,014,239 | $24.9M | 1.92% |
| 22 | ZAI LAB LTD | ZLAB | 865,297 | $24.0M | 1.85% |
| 23 | IMMATICS N.V | IMTX | 1,984,813 | $22.9M | 1.77% |
| 24 | AUTOLUS THERAPEUTICS PLC | AUTL | 9,217,150 | $21.9M | 1.70% |
| 25 | VOR BIOPHARMA INC | VOR | 6,461,467 | $20.0M | 1.54% |
| 26 | MADRIGAL PHARMACEUTICALS INC | MDGL | 85,000 | $19.6M | 1.52% |
| 27 | VERONA PHARMA PLC | 925050106 | 893,861 | $18.9M | 1.46% |
| 28 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 369,615 | $18.9M | 1.46% |
| 29 | THESEUS PHARMACEUTICALS INC | 88369M101 | 1,950,327 | $18.2M | 1.41% |
| 30 | KURA ONCOLOGY INC | KURA | 1,004,908 | $10.6M | 0.82% |